CTI BioPharma
CTIC
$9.09
Share price
0.00%
Change (1 day)
30.79%
Change (1 year)
Categories
CTI BioPharma (CTIC) - Total assets
Total assets on the balance sheet as of March 2023 : $0.11 B
According to CTI BioPharma 's latest financial reports the company's total assets are $0.11 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
CTI BioPharma - Total assets on balance sheet (from 2001 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.12 B | 73.85% |
| 2021-12-31 | $72.43 M | 24.37% |
| 2020-12-31 | $58.24 M | 25.84% |
| 2019-12-31 | $46.28 M | -48.48% |
| 2018-12-31 | $89.83 M | 63.67% |
| 2017-12-31 | $54.88 M | -14.03% |
| 2016-12-31 | $63.84 M | -55.77% |
| 2015-12-31 | $0.14 B | 56.39% |
| 2014-12-31 | $92.28 M | -1.53% |
| 2013-12-31 | $93.72 M | 27.15% |
| 2012-12-31 | $73.71 M | 18.44% |
| 2011-12-31 | $62.23 M | 16.13% |
| 2010-12-31 | $53.59 M | -22.99% |
| 2009-12-31 | $69.59 M | 8.33% |
| 2008-12-31 | $64.24 M | -12.61% |
| 2007-12-31 | $73.51 M | -27.8% |
| 2006-12-31 | $0.10 B | -34.49% |
| 2005-12-31 | $0.15 B | -15.98% |
| 2004-12-31 | $0.18 B | 26.63% |
| 2003-12-31 | $0.14 B | -21.78% |
| 2002-12-31 | $0.18 B | -38.51% |
| 2001-12-31 | $0.30 B |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $99.94 B | 88,920.41% | 🇨🇭 Switzerland |
 Eli Lilly LLY | $64.00 B | 56,910.03% | 🇺🇸 USA |
 Amgen AMGN | $97.15 B | 86,434.49% | 🇺🇸 USA |
 Baxter BAX | $28.27 B | 25,085.26% | 🇺🇸 USA |
 Incyte INCY | $6.78 B | 5,940.78% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $95.15 B | 84,657.55% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $43.47 B | 38,626.49% | 🇮🇱 Israel |